Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate in X-linked adrenoleukodystrophy
NL-OMON24772Recruiting
- Sponsor
- University of Amsterdam
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bezafibrate in adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN), sponsored by University of Amsterdam. Primary endpoints: Plasma lipid profile, Very long chain fatty acids in blood compartments and 1 more. Started Jul 2010; status: recruiting.
02
Drugs
bezafibrate
03
Conditions
adrenoleukodystrophy (ALD)adrenomyeloneuropathy (AMN)
Beyond the preview
Go deeper on NL-OMON24772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24772.